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Abstract: This study quantified changes in the DNA content and extracellular matrix composition of
both the cartilaginous repair tissue and the adjacent cartilage in a large animal model of a chondral
defect treated by subchondral drilling. Content of DNA, proteoglycans, and Type II and Type
I collagen, as well as their different ratios were assessed at 6 months in vivo after treatment of
full-thickness cartilage defects in the femoral trochlea of adult sheep with six subchondral drill holes,
each of either 1.0 mm or 1.8 mm in diameter by biochemical analyses of the repair tissue and the
adjacent cartilage and compared with the original cartilage. Only subchondral drilling which were
1.0 mm in diameter significantly increased both DNA and proteoglycan content of the repair tissue
compared to the original cartilage. DNA content correlated with the proteoglycan and Type II collagen
content within the repair tissue. Significantly higher amounts of Type I collagen within the repair
tissue and significantly increased DNA, proteoglycan, and Type I collagen content in the adjacent
cartilage were identified. These translational data support the use of small-diameter bone-cutting
devices for marrow stimulation. Signs of early degeneration were present within the cartilaginous
repair tissue and the adjacent cartilage.
Keywords: articular cartilage; marrow stimulation; subchondral drilling; early osteoarthritis;
extracellular matrix; proteoglycan; Type I collagen; Type II collagen; DNA
1. Introduction
Marrow stimulation techniques, such as subchondral drilling [1], are established first-line treatment
options for symptomatic small articular cartilage defects of less than 3 cm2 [2,3]. Its common principle
is the surgical creation of multiple perforations of the subchondral bone plate, such as by the use of
a drill bit, allowing for the access of reparative multipotent progenitor cells from the subchondral
bone marrow cavity to the cartilage lesion [4]. Marrow stimulation techniques have been proven to
provide good clinical function and pain relief at the short- and mid-term [5]. Long-term outcomes
are mainly deteriorated by the incapacity of the cartilaginous repair tissue to permanently withstand
mechanical load and prevent perifocal osteoarthritis (OA) [6]. Here, the early phases of this degenerative
process have especially been gaining attention as of late; that is, the period of the disease when some
regenerative capacity of the articular cartilage is still preserved [7].
Interestingly, the effect of the subchondral drill hole diameter has only recently been investigated,
suggesting a supremacy of small- (≤1.0 mm) versus large-diameter (≥1.5 mm) perforations for the
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histological aspect of the cartilaginous repair tissue and for micro-computed tomography (micro-CT)
parameters of subchondral bone reconstitution [8,9]. However, such a possible effect of drill hole
size on the extracellular matrix (ECM) composition and molecular properties of the repair tissue
remains unknown. Besides, the biochemical composition of the repair cartilage has been compared
only very infrequently with those of the original articular cartilage and the cartilage adjacent to the
defects [10,11], and almost never in the context of marrow stimulation. Such biochemical evaluations
usually rely on an established and standardized determination of DNA (as a surrogate of the cell
number), proteoglycan, Type II and Type I collagen content [12,13], and have already been applied
successfully to determine the effect of cell-based treatments for articular cartilage defects in large
animal models [14–16]. Further, the biochemical composition of articular cartilage is thought to be a
surrogate for its mechanical properties [15,17].
The present study compares the effect of two different drill hole diameters in a large animal
model of the repair of a full-thickness chondral defect on the complex interrelationship of the cells
and their ECM within both the cartilaginous repair tissue and the articular cartilage adjacent to the
defects at 6 months in vivo. Specifically, we tested the hypothesis that small-diameter drill holes
would improve the ECM composition of the cartilaginous repair tissue compared with larger holes.
We further analysed the adjacent articular cartilage for signs of early degeneration.
2. Methods
2.1. Study Design
The aim of this study was to quantify and to correlate the content of DNA and key components
of the ECM based on samples obtained in a previous investigation [9] by applying either 1.0 mm or
1.8 mm diameter subchondral drill holes to 4 × 8 mm standardized rectangular full-thickness chondral
removal sites (also termed cartilage defects) in the lateral femoral trochlea of adult Merino sheep.
The original articular cartilage (also termed normal cartilage) removed at the site of the defect creation
was stored. Cartilage removal sites were treated by subchondral drilling, applying two different hole
diameters (1.0 and 1.8 mm). After 6 months, animals were sacrificed and the cartilage repair tissues, as
well as cartilage samples adjacent to the defects were retrieved. First, the biochemical composition of
the repair tissues was compared between defects treated by 1.0 mm and 1.8 mm drill holes (termed 1.0
and 1.8 mm defects). Second, cartilage repair tissues from both treatment groups were compared with
normal and adjacent cartilage. Third, biochemical findings were correlated with previously reported
data [9] on histological cartilage and microstructural subchondral bone repair.
2.2. Animal Experiments
All animal experiments were conducted in agreement with the national legislation on protection
of animals and the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory
Animals (NIH Publication 85-23, Rev 1985) and were approved by the local governmental animal care
committee, as previously described [9]. The number of animals needed to treat was calculated based on
data from other translational cartilage defect models and according to previous recommendations [18].
Skeletally mature, healthy, female Merino sheep (n = 13; average age 35 ± 10 months; average body
weight 70± 16 kg) received water ad libitum and were fed a standard diet. All animals were continuously
monitored by a veterinarian. Osteoarthritis was excluded on preoperative radiographs. Anesthesia,
surgery, and postoperative treatment were performed as previously described [9,19,20]. Standardized
rectangular (4 × 8 mm) full-thickness chondral removal sites were created unilaterally on the lateral
facet of the femoral trochlea. The original articular cartilage from the defects was retrieved, stored at
−80 ◦C, and served as the normal control. Six uniform subchondral drill holes (diameters: 1.0 [n = 7]
or 1.8 mm [n = 6]) were then introduced perpendicular to the joint surface within each removal site in
a standardized fashion (depth 10.0 mm) using fluted K-wires with a threaded trocar tip under constant
irrigation by saline to avoid coagulation or thermal necrosis. The animals were allowed immediate full
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weightbearing. Animals were sacrificed 6 months post-operatively. The repair tissue of the distal halves
of the defects (4 × 4 mm), as well as biopsies of adjacent articular cartilage were collected for further
biochemical analyses. Adjacent cartilage samples were retrieved from an area of 4 × 3 mm directly
neighboring the defect sites distally. Normal, repair, and adjacent cartilage samples were cautiously
retrieved using a scalpel with a #15 blade and Dumont straight forceps with a fine tip. The effect of a
subchondral drill hole diameter on histological and micro-CT parameters of osteochondral repair in
these 13 animals had already been reported elsewhere [9].
2.3. Biochemical Analyses
Biochemical analysis was performed for (1) original cartilage removed during defect creation,
(2) repair cartilage of the distal defect halves, and (3) adjacent cartilage retrieved distally to the
defects at sacrifice. Thus, 39 samples of 13 animals were digested overnight at 60 ◦C in a
500 µg/mL papain solution [21–23]. DNA content was determined by Hoechst 33258 assay [22].
The bicinchoninic acid test was used for detecting general protein contents. Proteoglycan concentrations
were measured spectrophotometrically by binding to dimethylmethylene blue (DMMB) [23,24],
with chondroitin-6-sulfate serving as the standard. Type I and Type II collagen content was
determined using enzyme-linked immunosorbent assays (ELISA; MD Bioproducts, Saint Paul, MN,
USA). All measurements were performed using a spectrophotometer/fluorometer (GENios, Tecan,
Crailsheim, Germany).
2.4. Statistical Analysis
The two-sample t-test with unequal variances for independent, non-parametric data was applied
to compare results between 1.0 mm and 1.8 mm defects. For within-group comparisons, the Wilcoxon
signed-rank test for dependent, non-parametric data was employed. To determine the strength of
association between the obtained biochemical data and (1) the histological average total score value of
the repair tissue according to Sellers et al. [25], as well as (2) major micro-CT parameters of subchondral
bone reconstitution (bone mineral density [BMD] and bone volume fraction [BV/TV]) as reported earlier
for these defects [9], the non-parametric Spearman correlation coefficient (r) was used. A two-tailed
value of p < 0.05 was considered significant. All calculations were performed with OriginPro 8G
(OriginLab Corporation, Northampton, MA, USA).
3. Results
3.1. Biochemical Evaluation of the Original Articular Cartilage
DNA, proteoglycan, Type I and Type II collagen content of the normal articular cartilage,
removed intraoperatively during the defect creation in vivo, as well as the proteoglycan/DNA, Type II
collagen/DNA, Type I collagen/DNA, and Type I/Type II collagen ratios were not significantly different
between the two groups with the different drill hole diameters (Table 1).
Biochemical evaluation of the articular cartilage repair tissue:
Upon evaluation of the cartilaginous repair tissue retrieved at 6 months postoperatively, the
DNA, proteoglycan, Type I and Type II collagen contents, as well as the proteoglycan/DNA, Type II
collagen/DNA, Type I collagen/DNA, and Type I/Type II collagen ratios did not vary significantly
between the two groups (Table 1). DNA and proteoglycan content was 1.4- and 1.7-fold higher in 1.0
mm diameter defects compared with 1.8 mm diameter defects, without reaching statistical significance
(Table 1; p = 0.344 and p = 0.162, respectively). Type II collagen content in the 1.0 mm diameter defects
was 2.4-fold higher, together with a 1.5-fold higher Type II collagen/DNA ratio compared to 1.8 mm
diameter defects (both p ≥ 0.215). Type I collagen also increased 2.3-fold in 1.0 mm diameter defects,
and the Type I collagen/DNA ratio was 1.9-fold higher (both p ≥ 0.127) (Table 1).
When compared to the normal cartilage retrieved at the site of the defect, DNA (3.9-fold) and
proteoglycan (4.2-fold) content was significantly increased in 1.0 mm diameter defects (both p ≤ 0.015),
J. Clin. Med. 2020, 9, 1903 4 of 15
but not following 1.8 mm drilling (p = 0.072) (Table 2, Figure 1A–D). The repair tissue of both groups
also contained significantly more Type I collagen (60.8-fold) and had a higher Type I collagen/DNA
ratio (20.0-fold) than the original cartilage (1.0 mm defects: p ≤ 0.022; 1.8 mm defects: p ≤ 0.016) (Table 1,
Figure 2G–J, Figure 3).
3.2. Biochemical Analysis of the Adjacent Articular Cartilage
DNA, proteoglycan, Type I and Type II collagen content of the cartilage adjacent to the treated
cartilage defects, as well as the proteoglycan/DNA, Type II collagen/DNA, Type I collagen/DNA, and
Type I/Type II collagen ratios were not different between the two treatment groups (Table 1).
Compared to the normal articular cartilage, the cartilage adjacent to the defect treated with the two
different drill hole diameters contained significantly increased DNA (1.0 mm defects: 2.6-fold, p < 0.001;
1.8 mm defects: 2.0-fold, p = 0.006), proteoglycan (1.0 mm defects: 2.2-fold, p < 0.001; 1.8 mm defects:
1.8-fold, p = 0.037), and Type I collagen content (1.0 mm defects: 47.9-fold, p = 0.011; 1.8 mm defects:
55.5-fold, p = 0.012) and Type I collagen/DNA ratios (1.0 mm defects: 18.3-fold, p = 0.008; 1.8 mm
defects: 23.0-fold, p = 0.011) (Table 1, Table 2, Figure 3). No significant differences in Type II collagen
content (1.0 mm defects: 1.3-fold, p = 0.399; 1.8 mm defects: 1.7-fold, p = 0.063) and proteoglycan/DNA
ratios (1.0 mm defects: 0.9-fold, p = 0.252; 1.8 mm defects: 0.9-fold, p = 0.562) existed between adjacent
and original articular cartilage (Table 2, Figure 3).
3.3. Correlation Analysis between the Biochemical Parameters and Structural Indices of Osteochondral Repair
In both treatment groups, DNA content of the repair tissue correlated with the proteoglycan
content (r ≥ 0.829; p ≤ 0.042) and with its Type II collagen content (r ≥ 0.714; p ≤ 0.005). The Type II
collagen content also correlated with the proteoglycan content (r ≥ 0.943; p ≤ 0.005). Other correlations
were beyond statistical significance.
Within the articular cartilage adjacent to the treated chondral defects, Type II collagen content
also correlated with the proteoglycan content (r ≥ 0.821; p ≤ 0.023). No other significant correlations
existed between DNA, proteoglycan, and collagen content.
No significant correlations were detected between all biochemical parameters of the repair
tissue reported here and the historical histological average total score value of the repair tissue [25]
(1.0 mm defects: 19.21 ± 4.80, 0.011 < r < 0.751, 0.051 < p < 0.964; 1.8 mm defects: 25.43 ± 3.73,
0.085 < r < 0.544, 0.265 < p < 0.873). Individual histological score values, as well as the historical
major micro-CT parameters of the reconstituted subchondral bone plate and subarticular spongiosa
(BMD: 0.085 < r < 0.772, 0.071 < p < 0.873; BV/TV: 0.028 < r < 0.773, 0.069 < p < 0.958) [9] did not
significantly correlate.
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Table 1. Overview of the biochemical parameters obtained within original cartilage, repair cartilage, and adjacent cartilage.
Specimen Unit 1.0 mm 1.8 mm x-Fold Difference p
Original cartilage
DNA [ng/µg] 2.7−2 ± 0.9−2 3.3−2 ± 1.6−2 1.2 0.435
Proteoglycans [µg/µg] 8.4−3 ± 3.3−3 10.5−3 ± 6.7−3 1.3 0.514
Proteoglycans/DNA [µg/ng] 3.2−1 ± 0.7−1 3.3−1 ± 1.5−1 1.0 0.878
Type II collagen [µg/µg] 6.7−4 ± 5.0−4 5.6−4 ± 2.7−4 1.2 0.644
Type II collagen/DNA [µg/ng] 2.6−2 ± 1.5−2 1.8−2 ± 0.6−2 1.4 0.261
Type I collagen [µg/µg] 0.8−4 ± 0.5−4 0.8−4 ± 0.3−4 1.1 0.741
Type I collagen/DNA [µg/ng] 0.3−2 ± 0.2−2 0.3−2 ± 0.1−2 1.2 0.455
Type I/Type II collagen [µg/µg] 1.3−1 ± 1.0−1 1.4−1 ± 0.7−1 0.9 0.688
Repair cartilage
DNA [ng/µg] 10.5−2 ± 5.6−2 7.7−2 ± 4.8−2 1.4 0.344
Proteoglycans [µg/µg] 35.6−3 ± 21.3−3 21.4−3 ± 12.1−3 1.7 0.162
Proteoglycans/DNA [µg/ng] 3.2−1 ± 0.8−1 2.8−1 ± 0.5−1 1.2 0.271
Type II collagen [µg/µg] 26.9−4 ± 30.0−4 11.0−4 ± 6.4−4 2.4 0.215
Type II collagen/DNA [µg/ng] 2.3−2 ± 1.8−2 1.5−2 ± 0.4−2 1.5 0.287
Type I collagen [µg/µg] 48.6−4 ± 41.2−4 20.8−4 ± 9.9−4 2.3 0.127
Type I collagen/DNA [µg/ng] 6.0−2 ± 6.5−2 3.2−2 ± 2.0−2 1.9 0.324
Type I/Type II collagen [µg/µg] 1.8 ± 3.9 1.9 ± 1.5 1.0 0.505
Adjacent cartilage
DNA [ng/µg] 6.9−2 ± 1.2−2 6.6−2 ± 1.7−2 1.1 0.679
Proteoglycans [µg/µg] 18.7−3 ± 3.3−3 18.6−3 ± 4.2−3 1.0 0.968
Proteoglycans/DNA [µg/ng] 2.8−1 ± 0.6−1 2.9−1 ± 0.6−1 1.1 0.668
Type II collagen [µg/µg] 8.7−4 ± 3.5−4 9.3−4 ± 3.4−4 1.1 0.752
Type II collagen/DNA [µg/ng] 2.3−2 ± 1.8−2 1.5−2 ± 0.4−2 1.5 0.287
Type I collagen [µg/µg] 38.3−4 ± 27.3−4 44.4−4 ± 28.0−4 1.2 0.701
Type I collagen/DNA [µg/ng] 5.5−2 ± 3.5−2 6.9−2 ± 4.2−2 1.3 0.532
Type I/Type II collagen [µg/µg] 4.4 ± 4.1 4.8 ± 4.0 0.9 0.787
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Table 2. Statistical comparison between the biochemical parameters obtained within original cartilage, repair cartilage, and adjacent cartilage.
p
Drill Hole
Diameter Specimen DNA Proteoglycans Proteoglycans/DNA Type II Collagen
Type II






[ng/µg] [µg/µg] [µg/ng] [µg/µg] [µg/ng] [µg/µg] [µg/ng] [µg/µg]
1.0 mm Originalcartilage
Repair








cartilage 0.136 0.082 0.250 0.161 0.208 0.595 0.877 0.447
1.8 mm Originalcartilage
Repair








cartilage 0.596 0.610 0.737 0.565 0.920 0.099 0.092 0.133
J. Clin. Med. 2020, 9, 1903 7 of 15
Figure 1. Comparison of proteoglycan and DNA content within original and repair cartilage following
1.0 and 1.8 mm subchondral drilling. Following 1.0 mm drilling, repair cartilage exhibited significantly
increased DNA (A) and proteoglycan (C) content when compared with the original cartilage. In contrast,
DNA and proteoglycan content was not significantly affected in the group with 1.8 mm drilling (B,D).
The proteoglycan/DNA ratio was balanced in the 1.0 mm group, (E) whereas it decreased in the
1.8 mm group (F). Numbers 1–13 represent individual animals. Red dotted lines indicate mean values.
* p < 0.05.
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Figure 2. Comparison of Type I and Type II collagen content within original and repair cartilage
following 1.0 and 1.8 mm subchondral drilling. Within both groups, the repair cartilage showed
significantly increased Type I collagen content (A,B) and Type I collagen/DNA ratio (C,D) when
compared to the original articular cartilage, reflective of early osteoarthritis. Analysis of Type II collagen
content revealed no significant differences between repair and original cartilage (E–H). Numbers 1–13
represent individual animals. Red dotted lines indicate mean values. * p < 0.05.
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Figure 3. Overview of biochemical parameters and statistical comparison between original cartilage,
repair cartilage, and adjacent cartilage within both treatment groups.
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4. Discussion
The present study quantified the effect of two different drill hole diameters on the cells and their
ECM within the cartilaginous repair tissue and the articular cartilage adjacent to the defects in a
large animal model of marrow-stimulation-based chondral repair at 6 months in vivo. There are a
number of important conclusions arising from these data that expand our insight into this complex
interrelationship during the repair of focal articular cartilage defects and potential progression to joint
degeneration. The first major finding is that only 1.0 mm diameter subchondral drilling significantly
increases mean DNA and proteoglycan content of the cartilaginous repair tissue compared to the
original cartilage, but not 1.8 mm drilling, supporting the value of small-diameter bone-cutting devices
for marrow stimulation. Second, DNA content correlated with the proteoglycan and Type II collagen
content (which also correlated among themselves), suggesting an orchestrated deposition of ECM
within the cartilaginous repair tissue following subchondral drilling. Finally, and perhaps surprisingly,
signs of early tissue degeneration were already present both within the (fibro)cartilaginous repair
tissue, as indicated by the higher biochemical indices for Type I collagen, and the articular cartilage
adjacent to the defects, as revealed by the significantly increased DNA, proteoglycan, and Type I
collagen content without differences between the two treatment groups at 6 months in vivo.
Accurately assessing cells and ECM content within the cartilaginous repair tissue and the adjacent
articular cartilage by means of biochemical evaluations is mandatory for any comprehensive assessment
of the repair process, as it reflects the extent to which biological activity is stimulated in the cells, forming
the repair tissue and its vicinity [12]. These activities include cell number and proliferation—reflective
of the repopulation of a defect—as well as biosynthesis of ECM components required to support
the cartilage architecture and organization. Analysis of cell number and proliferation is regularly
performed by estimating DNA concentrations, such as by determining intercalation of a fluorescent
DNA dye [22]. Determination of ECM biosynthesis generally relies on the evaluation of proteoglycan
and collagen concentrations by DMMB assay or ELISA, respectively [12,26]. Such methods are
established to monitor the extent of cartilage repair using human samples [27] and in various animal
models, including rats [28], rabbits [29,30], sheep or goats [31,32], and horses [33,34], substantiating
their feasibility in clinically relevant settings. Furthermore, proteoglycan and collagen content has
been proven to mainly account for the compressive properties of normal articular cartilage [17,35],
underlining the importance of these parameters for cartilage repair strategies. To date, biomechanical
testing of the articular cartilage repair tissue following subchondral drilling has never been performed
in sheep, and only once in goats [36], underlining the need for further biomechanical testing in
translational investigations.
The data revealed considerable higher amounts of DNA (up to 3.9-fold), proteoglycan (up to
4.2-fold), and Type II collagen (up to 4.0-fold) content in the cartilaginous repair tissue following
subchondral drilling. Of note, following small (1.0 mm) diameter drilling, these numerical differences
were significant for mean DNA and proteoglycan concentrations (albeit not all individual animals
always exhibited such significant improvement). Yet, as this effect was not observed following large
(1.8 mm) diameter drilling, the data suggest a beneficial effect of small drill holes on the cell and
ECM content of the repair tissue. Interestingly, this finding is in good agreement with the histological
assessment of the cartilaginous repair tissue and the micro-CT analysis of the subchondral bone in these
defects [9]. Furthermore, regarding the clinically more frequently applied microfracture technique [37],
a recent investigation confirmed that small-diameter awls improve articular cartilage repair in sheep
more effectively than larger awls [8]. Of note, the ECM might further strengthen over time, as clinical
studies suggest a maturation of the repair tissue over several years [38,39].
Compared to the normal cartilage, Type I collagen content was significantly increased up to
60-fold within the repair tissue of either treatment group. In their classical biochemical studies,
Glimcher and coworkers identified Type II collagen as only predominant at 1–2 months in a rabbit
defect model, while Type I collagen persisted for up to 1 year [10]. Thus, the benefits of increased
proteoglycan and DNA content in the repair tissue following subchondral drilling at 6 months
J. Clin. Med. 2020, 9, 1903 11 of 15
postoperatively need to be weighed against the significant presence of Type I collagen, which is
associated with a fibrocartilaginous phenotype. This finding is supported by the reported occurrence of
moderate to severe surface fibrillation and irregularity of the repair tissue [9] which corresponds to an
OARSI (Osteoarthritis Research Society International) grade 3.0 [40], thus unveiling fibrocartilaginous
characteristics [41]. While articular cartilage repair is often regarded as the sole important outcome of
studies on focal cartilage defects, it is important to remember that even small chondral lesions may
induce early OA in the affected joint compartment [42], as shown in a similar model by Schinhan and
Nehrer [6] and in long-term clinical evaluations [43,44].
OA is an insidious disease, and may be present long before arising to a clinically symptomatic
state. We substantiated degenerative changes within the adjacent articular cartilage following either
subchondral drilling technique, exhibiting an up to 55-fold increase in Type I collagen content
compared with the normal cartilage. Interestingly, no significant differences in Type II collagen
content was identified, indicating that the collagenous network of the adjacent cartilage was not yet
affected. Both DNA and proteoglycan content was significantly elevated, most likely representing
an early attempt to restore these lost ECM components adjacent to the lesion, as seen in the early
hypertrophic phase of OA, suggesting that at this time-point, the rate of repair is greater than the
rate of degradation [45]. Altogether, these findings point towards an early, but not advanced stage
of OA within the articular cartilage adjacent to the treated cartilage removal sites [7]. However, the
presented data do not allow to judge whether subchondral drilling per se has the potential to diminish
degenerative changes within the repaired and adjacent cartilage. For this purpose, a control group of
untreated cartilage removal sites would be necessary. Although marrow stimulation could not prevent
such degenerative changes in a sheep study applying the microfracture technique [8], this important
aspect remains to be elucidated in future investigation of subchondral drilling.
Of note, proteoglycan content of the cartilaginous repair tissue correlated with DNA and
Type II collagen content in both groups, which is in good agreement with previous studies [45,46].
Interestingly, no significant correlation was found between the evaluated biochemical parameters of
the cartilaginous repair tissue and its histological or radiological parameters of osteochondral repair
reported earlier for these defects [9]. The absence of such external correlations between different
methods of evaluation is in line with preceding reports, indicating that time-dependent osteochondral
repair mechanisms are lacking synchronization [47] and proceed at a different pace [48] in both small
and large animal models [9]. Thus, biochemical, histological, and radiological evaluations may be
considered as complementary, rather than replaceable tools to assess experimental articular cartilage
repair in vivo [46]. It remains to be elucidated whether these parameters may correlate with functional
results of patients in a clinical situation.
Possible limitations of this study include the selection of a single time-point postoperatively,
precluding an assessment of changes over time, as stipulated by our animal license, and the lack of
biomechanical testing. However, the possibility of comparing for each animal the characteristics of
the original tissue present at the site and the time of articular cartilage removal with its individual
repair tissue at the identical location allowed for important insights, besides the comparison between
the 1.0 and 1.8 mm diameter instruments. Such comparison with the normal control in a pre- versus
post-treatment longitudinal study design is an established and reliable statistical approach [49–51].
Other strengths are the inclusion of several relevant and objective biochemical parameters, as well as
their correlation with a number of indices of osteochondral repair, serving as historical control and a
gold standard of evaluation. With a view on OA possibly encroaching on formerly unaffected joint
areas originating from such defects, it will be important to complement these biochemical observations
at mid-term with data from longer observation periods to answer the question on whether the reported
changes may further progress towards higher degrees of OA in the future.
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5. Conclusions
This study provides insight into the complex interrelationship of cells and their ECM during the
repair of focal articular cartilage defects and their potential progression to joint degeneration between a
focal chondral defect in a previously normal knee joint during its repair, based on a marrow-stimulation
technique and the affected adjacent articular cartilage. From a clinical perspective, these translational
data support the hypothesis that small-diameter bone-cutting devices improve marrow-stimulation
of a focal chondral defect, although signs of early degeneration were present not only within the
cartilaginous repair tissue, but also in the adjacent articular cartilage.
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